Obstetrics & Gynecology Science

CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Prevalence of tumor BRCA1 and BRCA2 dysfunction in unselected patients with ovarian cancer

Roshni D. Kalachand, Ciaran O’Riain, Sinead Toomey, Aoife Carr, Kirsten M. Timms, Sharon O’Toole, Stephen Madden, Mark Bates, John J. O’Leary, Noreen Gleeson, Dearbhaile O’Donnell, Liam Grogan, Oscar Breathnach, Angela Farrelly, Britta Stordal, Bryan T. Hennessy

Obstet Gynecol Sci. 2020;63(5):643-654. Published online September 2, 2020
DOI: https://doi.org/10.5468/ogs.20033

Estimating survival rates after ovarian cancer among women tested for BRCA1 and BRCA2 mutations

SA Narod, JRK Moody, B Rosen, I Fan, A Risch, P Sun, JR McLaughlin

Clinical Genetics. 2013;83(3):232-237

Link1 Link2

High prevalence of BRCA1 and BRCA2 mutations in unselected Nigerian breast cancer patients

James D. Fackenthal, Jing Zhang, Bifeng Zhang, Yonglan Zheng, Fitsum Hagos, Devin R. Burrill, Qun Niu, Dezheng Huo, Walmy E. Sveen, Temidayo Ogundiran, Clemet Adebamowo, Abayomi Odetunde, Adeyinka G. Falusi, Olufunmilayo I. Olopade

International Journal of Cancer. 2012;131(5):1114-1123

Link1

Founder BRCA1 and BRCA2 mutations in French Canadian ovarian cancer cases unselected for family history

Patricia N Tonin, Anne-Marie Mes-Masson, Steven A Narod, Parviz Ghadirian, Diane Provencher

Clinical Genetics. 1999;55(5):318-324

Link1 Link2 Link3

Prevalence of tumor BRCA1 and BRCA2 dysfunction in unselected patients with ovarian cancer

Obstetrics & Gynecology Science. 2020;63(5):643-654

Link1

Link2 Link3

Frequency of BRCA1 and BRCA2 Mutations in Individuals with Breast and Ovarian Cancer in a Chinese Hakka Population Using Next-Generation Sequencing

Heming Wu, Qiuming Wang, Xuemin Guo, Qinghua Liu, Qunji Zhang, Qingyan Huang, Zhikang Yu

Human Heredity. 2019;84(4-5):160-169

Link1 Link2

Prevalence and Penetrance of BRCA1 and BRCA2 Germline Mutations in Colombian Breast Cancer Patients

D. Torres, J. Lorenzo Bermejo, M. U. Rashid, I. Briceño, F. Gil, A. Beltran, V. Ariza, U. Hamann

Scientific Reports. 2017;7(1):

Link1

Link2 Link3

The clinical implications of genetics. BRCA1- and BRCA2-positive: how do I proceed? Implications for ovarian cancer prevention

R.H.M. Verheijen, B. Hermsen

Annals of Oncology. 2008;19:v84-v86

Link1 Link2 Link3

BRCA1 and BRCA2 germline mutation spectrum and frequencies in Belgian breast/ovarian cancer families

K Claes, B Poppe, I Coene, A De Paepe, L Messiaen

British Journal of Cancer. 2004;90(6):1244-1251

Link1

Link2 Link3

The Tyr978X BRCA1 Mutation in Non-Ashkenazi Jews: Occurrence in High-Risk Families, General Population and Unselected Ovarian Cancer Patients

Ronit Shiri-Sverdlov, Ruth Gershoni-Baruch, Galit Ichezkel-Hirsch, Walter H. Gotlieb, Revital Bruchim Bar-Sade, Angela Chetrit, Shulamith Rizel, Baruch Modan, Eitan Friedman

Public Health Genomics. 2001;4(1):50-55

Link1 Link2

Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from Greece

Chrissovaladis Koumpis, Constantine Dimitrakakis, Aris Antsaklis, Robert Royer, Shiyu Zhang, Steven A Narod, Joanne Kotsopoulos

Hereditary Cancer in Clinical Practice. 2011;9(1):

Link1

Link2 Link3 Link4